Nov 30, 2020 | Case Study, Company News, Genius Suite
Digital technologies have been used in clinical studies for years. So far, however, they have been used very hesitantly by sponsors, study centers and CROs. Authorities have also been very hesitant to approve their use. The Covid-19 pandemic, however, has changed this...
Nov 9, 2020 | Company News, Upcoming Events
Digital technologies have been used in clinical studies for years. So far, however, they have been used very hesitantly by sponsors, study centers and CROs. Authorities have also been very hesitant to approve their use. The Covid-19 pandemic, however, has changed this...
Sep 17, 2020 | Articles, Clinical Trial News, Genius Suite
In the aftermath of the Covid-19 pandemic, there was a debate both on the limits of typical on-site monitoring visits and on whether alternative technology-based solutions should continue to be used, even under normal conditions. As known during the pandemic, the...
Sep 9, 2020 | Company News
Milan, Italy – Exom Group is proud to announce, that we have been awarded the 2020 Healthcare & Pharmaceutical Award for “Most Innovative Clinical Trials Virtualisation CRO 2020”. As an awardee Exom needed to demonstrate expertise within our field, dedication to...
Jun 17, 2020 | Articles, Company News, Genius Suite
Exom Group Srl, in collaboration with Meteda Srl, announces the release of Genius FIRE Diabetes, the first large-scale eSource infrastructure operating in Europe for more efficient conduction of Clinical Trials in Diabetes. As is well known, Diabetes is one of the...
